News

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...
Androgen deprivation is the mainstay of advanced prostate cancer treatment ... large Phase III trials showed improvements in survival and outcomes and led to the approval of a CYP17 inhibitor ...
Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...
To examine the association of healthy lifestyle and diet on survival ... on prostate cancer outcomes. Nevertheless, the trends identified in this research offer valuable insights for designing ...
In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer ...
Quoc-Dien Trinh, MD, MBA, discusses a sub-analysis of the phase 3 ARANOTE trial, which focused on Black patients with metastatic hormone-sensitive prostate cancer.
The findings, published in Cancer Discovery, offer crucial insights ... resistant prostate cancer patients, potentially improving treatment results and increasing survival rates." ...
“A number of treatment options are now available to increase survival for patients ... “Our expansion into metastatic prostate cancer underscores the power of the Veracyte Diagnostics Platform ...
The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...
They are more prone to metastasis and drug resistance, which is consistent with a 5-year survival ... types within cancer." The new findings offer important insights into how prostate cancer ...
President Biden's prostate cancer diagnosis highlights the need for regular screenings, even here in Central Georgia.